|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
B
|
|
INDICATIONS:
|
|
|
|
SIDE EFFECTS:
|
|
Contact dermatitis or hypersensitivity |
|
Pseudomembranous colitis |
|
Dryness, scaliness, or peeling of skin |
|
Gastrointestinal disturbances |
|
irritation, sensitization or oiliness of skin |
|
stinging or burning feeling of skin |
|
Abdominal or stomach cramps, pain, and bloating, severe |
|
diarrhea, watery and severe, which may also be bloody |
|
fever |
|
increased thirst |
|
nausea or vomiting |
|
unusual tiredness or weakness |
|
weight loss, unusual |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
Antibiotic-associated colitis, ulcerative colitis, or regional enteritis |
|
|
ADULT DOSE:
|
|
Antiacne agent (topical)-Topical, to the skin, two times a day to the affected areas.
Note: Solutions have been used one to four times a day. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Children up to 12 years of age-Safety and efficacy have not been established. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|